Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen Farrell

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Chemotherapy|May 20, 2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanomaPatrick A Ott, Jason L Chang, Ruth Oratz, et al.
The Journal of Pediatrics|September 10, 2018
Comorbidities of Rare Epilepsies: Results from the Rare Epilepsy NetworkNhan Thi Ho, Barbara Kroner, Zachary Grinspan, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|April 11, 2022
Occupational engagement, fatigue, and upper and lower extremity abilities in persons with melorheostosisKathleen Farrell, Leora E Comis, Morgan M Casimir, et al.
Epilepsy & Behavior : E&B|February 15, 2021
Establishing a learning healthcare system to improve health outcomes for people with epilepsyMaria A Donahue, Susan T Herman, Deepika Dass, et al.
Neuromuscular Disorders : NMD|March 20, 2022
Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophyThomas C Bulea, Amanda Guth, Nathan Sarkar, et al.
Neurology|September 8, 2017
Reducing placebo exposure in trials: Considerations from the Research Roundtable in EpilepsyBrandy E Fureman, Daniel Friedman, Michel Baulac, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumorsAnna C Pavlick, Jennifer Wu, John Roberts, et al.
Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Neurology. Clinical Practice|November 29, 2024
Barriers to Medication Adherence in People Living With EpilepsyMaria Andrea Donahue, Hammad Akram, Julianne D Brooks, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Chemotherapy|May 20, 2009
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanomaPatrick A Ott, Jason L Chang, Ruth Oratz, et al.
The Journal of Pediatrics|September 10, 2018
Comorbidities of Rare Epilepsies: Results from the Rare Epilepsy NetworkNhan Thi Ho, Barbara Kroner, Zachary Grinspan, et al.
PM & R : the Journal of Injury, Function, and Rehabilitation|April 11, 2022
Occupational engagement, fatigue, and upper and lower extremity abilities in persons with melorheostosisKathleen Farrell, Leora E Comis, Morgan M Casimir, et al.
Epilepsy & Behavior : E&B|February 15, 2021
Establishing a learning healthcare system to improve health outcomes for people with epilepsyMaria A Donahue, Susan T Herman, Deepika Dass, et al.
Neuromuscular Disorders : NMD|March 20, 2022
Simple and economical HandClench Relaxometer device for reliable and sensitive measurement of grip myotonia in myotonic dystrophyThomas C Bulea, Amanda Guth, Nathan Sarkar, et al.
Neurology|September 8, 2017
Reducing placebo exposure in trials: Considerations from the Research Roundtable in EpilepsyBrandy E Fureman, Daniel Friedman, Michel Baulac, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2009
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumorsAnna C Pavlick, Jennifer Wu, John Roberts, et al.
Epilepsia|July 14, 2022
Considerations for determining the efficacy of new antiseizure medications in children age 1 month to younger than 2 yearsJacqueline A French, Elena Cleary, Dennis Dlugos, et al.
Neurology. Clinical Practice|November 29, 2024
Barriers to Medication Adherence in People Living With EpilepsyMaria Andrea Donahue, Hammad Akram, Julianne D Brooks, et al.
Pageof 3